What to expect
US Insights (Regulation, Policy & Market Trends): Stay ahead of U.S. regulatory shifts, tariff realities, reshoring pressures, and policy changes that directly shape pharma strategy and supply chain resilience.
R&D Excellence – Biologics: Discover the evolving biotech ecosystem, from funding and collaboration models to the maturation of cell and gene therapies that accelerate innovation and pipeline growth.
US Manufacturing Excellence: Explore how to modernize and strengthen U.S. pharmaceutical manufacturing through innovation, digital transformation, and operational excellence for greater efficiency and competitiveness.
Supply Chain, AI & Emerging Technologies: Harness AI, digital twins, cybersecurity, and emerging technologies to build resilient, agile supply chains and unlock enterprise-scale innovation in pharma operations.
Future Market Strategy: Master long-term market positioning with scenario planning, narrative-building, and strategic frameworks to future-proof your organization in a complex, policy-driven global landscape.